SGF29 and glioblastoma: Next, we examined the response of SGF29-dependent MV4-11 leukemia cells and the SGF29-independent U251 glioblastoma cells (see Fig. 1H) to these 190 candidate compounds (plus 15 reference compounds) using a CellTiter Glo screen.